GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Membrane-type 1 Matrix Metalloproteinase in COPD

$123,800
Jeffrey J Atkinson · Washington University · K08 · FY2008 · HL

Translational Pathology Shared Resource

$123,621
Sarah M. Dry · University Of California Los Angeles · P30 · FY2011 · CA

Molecular Mechanisms for Growth Factor Action of Gastrin

$123,620
Andrea Todisco · University Of Michigan At Ann Arbor · R01 · FY2007 · DK

Health Disparities in Alzheimer's Disease and Mild Cognitive Impairment among Mexican Americans

$123,580
Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · R01 · FY2018 · AG

Clinical Investigation in Pancreatic & Biliary Disorders

$123,462
Charles Wilcox · University Of Alabama At Birmingham · K24 · FY2009 · DK

Biospecimen Core

$123,458
Olca Basturk · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA

Developmental Research Program

$123,458
Jason S Lewis · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA

Biostatistics Core

$123,458
Marinela Capanu · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA

Developmental Program

$123,434
Bert Vogelstein · Johns Hopkins University · P50 · FY2015 · CA

TARGETING CCR2 TO OVERCOME IMMUNOSUPPRESSION AND IMPROVE IMMUNOTHERAPY

$123,411
David G Denardo · Washington University · R21 · FY2014 · CA

Core C: Human Studies Core

$123,405
Dennis M Jensen · University Of California Los Angeles · P30 · FY2018 · DK

PD2/Paf1 and pancreatic cancer stem cells

$123,278
Moorthy P. Ponnusamy · University Of Nebraska Medical Center · K22 · FY2014 · CA

Hormonal Regulation of mRNA Stability

$123,218
Daniel R. Schoenberg · Ohio State University · R01 · FY2009 · GM

Novel oncolytic adenovirus for pancreatic therapy

$123,200
Baek Kim · University Of Rochester · R21 · FY2007 · CA

Developmental Fund

$123,160
Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2012 · CA

Stromal depletion for pancreatic cancer therapy

$123,139
Shyh-Dar Li · University Of British Columbia · R21 · FY2014 · CA

A Targeted Preemptive Approach to Addressing Mitochondrial Toxicity of Nucleoside

$123,131
John K. Buolamwini · University Of Tennessee Health Sci Ctr · R01 · FY2014 · GM

Quantitative glycoproteomics for pancreatic cancer studies

$123,122
Sheng Pan · University Of Washington · K25 · FY2013 · CA

Quantitative glycoproteomics for pancreatic cancer studies

$123,122
Sheng Pan · University Of Washington · K25 · FY2011 · CA

Quantitative glycoproteomics for pancreatic cancer studies

$123,122
Sheng Pan · University Of Washington · K25 · FY2014 · CA

Quantitative glycoproteomics for pancreatic cancer studies

$123,122
Sheng Pan · University Of Washington · K25 · FY2012 · CA

Disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer

$122,890
Christopher J. Halbrook · University Of Michigan At Ann Arbor · K99 · FY2020 · CA

Mediators of pancreatic cancer induction by alcoholic pancreatitis and smoking

$122,886
Mouad Edderkaoui · Brentwood Biomedical Research Institute · K01 · FY2012 · AA

Inhibition of Recombination DNA Repair in Pancreatic Cancer Cells

$122,800
Philip Paul Connell · University Of Chicago · R21 · FY2007 · CA

Molecular Mechanisms of Growth Factor Modulated Proliferation

$122,710
William Farrar · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA